Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1JP5

Crystal structure of the single-chain Fv fragment 1696 in complex with the epitope peptide corresponding to N-terminus of HIV-1 protease

Summary for 1JP5
Entry DOI10.2210/pdb1jp5/pdb
Related1CL7 1MF2 2HRP
Descriptorsingle-chain Fv fragment 1696, epitope peptide corresponding to N-terminus of HIV-1 protease (3 entities in total)
Functional Keywordsantibody-antigen complex, hiv pr inhibiting antibody, immune system
Biological sourceMus musculus (house mouse)
More
Total number of polymer chains4
Total formula weight56152.11
Authors
Rezacova, P.,Lescar, J.,Brynda, J.,Fabry, M.,Horejsi, M.,Sedlacek, J.,Bentley, G.A. (deposition date: 2001-08-01, release date: 2001-10-12, Last modification date: 2024-11-13)
Primary citationRezacova, P.,Lescar, J.,Brynda, J.,Fabry, M.,Horejsi, M.,Sedlacek, J.,Bentley, G.A.
Structural basis of HIV-1 and HIV-2 protease inhibition by a monoclonal antibody.
Structure, 9:887-895, 2001
Cited by
PubMed Abstract: Since the demonstration that the protease of the human immunodeficiency virus (HIV Pr) is essential in the viral life cycle, this enzyme has become one of the primary targets for antiviral drug design. The murine monoclonal antibody 1696 (mAb1696), produced by immunization with the HIV-1 protease, inhibits the catalytic activity of the enzyme of both the HIV-1 and HIV-2 isolates with inhibition constants in the low nanomolar range. The antibody cross-reacts with peptides that include the N terminus of the enzyme, a region that is highly conserved in sequence among different viral strains and that, furthermore, is crucial for homodimerization to the active enzymatic form.
PubMed: 11591344
DOI: 10.1016/S0969-2126(01)00654-2
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7 Å)
Structure validation

237992

数据于2025-06-25公开中

PDB statisticsPDBj update infoContact PDBjnumon